Specific aims of the project include:
- The development and optimization of an experimental protocol for high-throughput small compound screening.
- The implementation of the screening and candidate validation.
- The characterization of the mode of action of validated candidate compounds.
More about us:
The Sixt lab is part of the Laboratory for Molecular Infection Medicine Sweden (MIMS) and the Umeå Centre for Microbial Research (UCMR), an interdisciplinary research center devoted to top quality research and novel applications in the field of microbiology. You can find more information about us at www.mims.umu.se/groups/barbara-sixt; www.ucmr.umu.se, and www.molbiol.umu.se/english.